Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy

Published:2019-04 Issue:4 Volume:45 Page:644-649
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Lee Yong Jae,Chung Young Shin,Lee Jung-Yun,Nam Eun Ji,Kim Sang Wun,Kim Sunghoon,Kim Young Tae

Funder

Bio & Medical Technology Development Program of the National Research Foundation (NRF)

Ministry of Science, ICT & Future Planning

Yonsei University College of Medicine

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference26 articles.

1. Significance of postoperative CA-125 decline after cytoreductive surgery in stage IIIC/IV ovarian cancer;Yoo;J Gynecol Oncol,2008

2. Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer;Zivanovic;Gynecol Oncol,2009

3. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer;Kim;Onkologie,2008

4. Significance of early changes in the serum CA-125 antigen level on overall survival in advanced ovarian cancer;Markman;Gynecol Oncol,2006

5. Clinical significance of CA125 level after the first cycle of chemotherapy on survival of patients with advanced ovarian cancer;Lee;Yonsei Med J,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience

;Cancer Management and Research;2019-07